INGERSOLL-RAND INC (IR) Fundamental Analysis & Valuation

NYSE:IR • US45687V1061

Current stock price

81.39 USD
-0.77 (-0.94%)
At close:
81.39 USD
0 (0%)
After Hours:

This IR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. IR Profitability Analysis

1.1 Basic Checks

  • In the past year IR was profitable.
  • In the past year IR had a positive cash flow from operations.
  • In the past 5 years IR has always been profitable.
  • IR had a positive operating cash flow in each of the past 5 years.
IR Yearly Net Income VS EBIT VS OCF VS FCFIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

1.2 Ratios

  • IR has a Return On Assets (3.18%) which is in line with its industry peers.
  • IR's Return On Equity of 5.76% is in line compared to the rest of the industry. IR outperforms 48.09% of its industry peers.
  • IR has a Return On Invested Capital (7.13%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IR is below the industry average of 10.16%.
  • The last Return On Invested Capital (7.13%) for IR is above the 3 year average (6.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.18%
ROE 5.76%
ROIC 7.13%
ROA(3y)4.28%
ROA(5y)4.13%
ROE(3y)7.32%
ROE(5y)6.96%
ROIC(3y)6.98%
ROIC(5y)5.92%
IR Yearly ROA, ROE, ROICIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10 15

1.3 Margins

  • With a decent Profit Margin value of 7.60%, IR is doing good in the industry, outperforming 64.12% of the companies in the same industry.
  • IR's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 19.73%, IR belongs to the best of the industry, outperforming 89.31% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IR has grown nicely.
  • IR's Gross Margin of 43.61% is amongst the best of the industry. IR outperforms 81.68% of its industry peers.
  • In the last couple of years the Gross Margin of IR has grown nicely.
Industry RankSector Rank
OM 19.73%
PM (TTM) 7.6%
GM 43.61%
OM growth 3Y9.9%
OM growth 5Y23.36%
PM growth 3Y-9.41%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y4.28%
IR Yearly Profit, Operating, Gross MarginsIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

6

2. IR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IR is destroying value.
  • IR has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, IR has less shares outstanding
  • The debt/assets ratio for IR has been reduced compared to a year ago.
IR Yearly Shares OutstandingIR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
IR Yearly Total Debt VS Total AssetsIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • IR has an Altman-Z score of 3.42. This indicates that IR is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of IR (3.42) is better than 60.31% of its industry peers.
  • IR has a debt to FCF ratio of 3.92. This is a good value and a sign of high solvency as IR would need 3.92 years to pay back of all of its debts.
  • IR has a Debt to FCF ratio of 3.92. This is comparable to the rest of the industry: IR outperforms 58.78% of its industry peers.
  • IR has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.47, IR is in line with its industry, outperforming 47.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.92
Altman-Z 3.42
ROIC/WACC0.75
WACC9.55%
IR Yearly LT Debt VS Equity VS FCFIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • IR has a Current Ratio of 2.06. This indicates that IR is financially healthy and has no problem in meeting its short term obligations.
  • IR has a Current ratio (2.06) which is comparable to the rest of the industry.
  • IR has a Quick Ratio of 1.49. This is a normal value and indicates that IR is financially healthy and should not expect problems in meeting its short term obligations.
  • IR has a better Quick ratio (1.49) than 64.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.49
IR Yearly Current Assets VS Current LiabilitesIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

5

3. IR Growth Analysis

3.1 Past

  • IR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.52%.
  • Measured over the past years, IR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.21% on average per year.
  • IR shows a small growth in Revenue. In the last year, the Revenue has grown by 5.75%.
  • IR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.00% yearly.
EPS 1Y (TTM)1.52%
EPS 3Y12.12%
EPS 5Y17.21%
EPS Q2Q%14.29%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y8.95%
Revenue growth 5Y14%
Sales Q2Q%10.14%

3.2 Future

  • IR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.88% yearly.
  • The Revenue is expected to grow by 8.00% on average over the next years.
EPS Next Y9.21%
EPS Next 2Y9.73%
EPS Next 3Y9.82%
EPS Next 5Y13.88%
Revenue Next Year4.9%
Revenue Next 2Y4.85%
Revenue Next 3Y4.95%
Revenue Next 5Y8%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IR Yearly Revenue VS EstimatesIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
IR Yearly EPS VS EstimatesIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

2

4. IR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 24.37, which indicates a rather expensive current valuation of IR.
  • The rest of the industry has a similar Price/Earnings ratio as IR.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, IR is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 22.31, the valuation of IR can be described as rather expensive.
  • IR's Price/Forward Earnings is on the same level as the industry average.
  • IR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.28.
Industry RankSector Rank
PE 24.37
Fwd PE 22.31
IR Price Earnings VS Forward Price EarningsIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as IR.
  • IR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.12
EV/EBITDA 17.72
IR Per share dataIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IR does not grow enough to justify the current Price/Earnings ratio.
  • IR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.65
PEG (5Y)1.42
EPS Next 2Y9.73%
EPS Next 3Y9.82%

3

5. IR Dividend Analysis

5.1 Amount

  • IR has a yearly dividend return of 0.10%, which is pretty low.
  • IR's Dividend Yield is comparable with the industry average which is at 1.19.
  • With a Dividend Yield of 0.10, IR pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.1%

5.2 History

  • IR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IR Yearly Dividends per shareIR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 5.47% of the earnings are spent on dividend by IR. This is a low number and sustainable payout ratio.
DP5.47%
EPS Next 2Y9.73%
EPS Next 3Y9.82%
IR Yearly Income VS Free CF VS DividendIR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B
IR Dividend Payout.IR Dividend Payout, showing the Payout Ratio.IR Dividend Payout.PayoutRetained Earnings

IR Fundamentals: All Metrics, Ratios and Statistics

INGERSOLL-RAND INC

NYSE:IR (3/20/2026, 8:04:00 PM)

After market: 81.39 0 (0%)

81.39

-0.77 (-0.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners106.27%
Inst Owner Change-2.42%
Ins Owners0.17%
Ins Owner Change2.45%
Market Cap31.87B
Revenue(TTM)7.65B
Net Income(TTM)581.40M
Analysts76.8
Price Target104.35 (28.21%)
Short Float %3.81%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield 0.1%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP5.47%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-04
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.13%
Min EPS beat(2)-2.93%
Max EPS beat(2)3.18%
EPS beat(4)1
Avg EPS beat(4)-1.76%
Min EPS beat(4)-4.75%
Max EPS beat(4)3.18%
EPS beat(8)4
Avg EPS beat(8)0.34%
EPS beat(12)8
Avg EPS beat(12)4.24%
EPS beat(16)12
Avg EPS beat(16)4.45%
Revenue beat(2)0
Avg Revenue beat(2)-1.55%
Min Revenue beat(2)-2.64%
Max Revenue beat(2)-0.47%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-3.44%
Max Revenue beat(4)-0.47%
Revenue beat(8)0
Avg Revenue beat(8)-2.69%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.4%
PT rev (1m)14.2%
PT rev (3m)16.71%
EPS NQ rev (1m)-3.19%
EPS NQ rev (3m)-3.7%
EPS NY rev (1m)-0.57%
EPS NY rev (3m)-1.31%
Revenue NQ rev (1m)-2.2%
Revenue NQ rev (3m)-2.51%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE 24.37
Fwd PE 22.31
P/S 4.17
P/FCF 26.12
P/OCF 23.51
P/B 3.16
P/tB N/A
EV/EBITDA 17.72
EPS(TTM)3.34
EY4.1%
EPS(NY)3.65
Fwd EY4.48%
FCF(TTM)3.12
FCFY3.83%
OCF(TTM)3.46
OCFY4.25%
SpS19.54
BVpS25.76
TBVpS-6.73
PEG (NY)2.65
PEG (5Y)1.42
Graham Number44
Profitability
Industry RankSector Rank
ROA 3.18%
ROE 5.76%
ROCE 9.3%
ROIC 7.13%
ROICexc 7.73%
ROICexgc 51.27%
OM 19.73%
PM (TTM) 7.6%
GM 43.61%
FCFM 15.95%
ROA(3y)4.28%
ROA(5y)4.13%
ROE(3y)7.32%
ROE(5y)6.96%
ROIC(3y)6.98%
ROIC(5y)5.92%
ROICexc(3y)7.73%
ROICexc(5y)6.64%
ROICexgc(3y)51.08%
ROICexgc(5y)43.67%
ROCE(3y)9.11%
ROCE(5y)7.72%
ROICexgc growth 3Y11.76%
ROICexgc growth 5Y33.98%
ROICexc growth 3Y9.56%
ROICexc growth 5Y36.29%
OM growth 3Y9.9%
OM growth 5Y23.36%
PM growth 3Y-9.41%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y4.28%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.92
Debt/EBITDA 2.37
Cap/Depr 26.81%
Cap/Sales 1.77%
Interest Coverage 6.06
Cash Conversion 67.27%
Profit Quality 209.86%
Current Ratio 2.06
Quick Ratio 1.49
Altman-Z 3.42
F-Score6
WACC9.55%
ROIC/WACC0.75
Cap/Depr(3y)26.9%
Cap/Depr(5y)23.55%
Cap/Sales(3y)1.79%
Cap/Sales(5y)1.64%
Profit Quality(3y)173.99%
Profit Quality(5y)149.33%
High Growth Momentum
Growth
EPS 1Y (TTM)1.52%
EPS 3Y12.12%
EPS 5Y17.21%
EPS Q2Q%14.29%
EPS Next Y9.21%
EPS Next 2Y9.73%
EPS Next 3Y9.82%
EPS Next 5Y13.88%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y8.95%
Revenue growth 5Y14%
Sales Q2Q%10.14%
Revenue Next Year4.9%
Revenue Next 2Y4.85%
Revenue Next 3Y4.95%
Revenue Next 5Y8%
EBIT growth 1Y4.1%
EBIT growth 3Y19.73%
EBIT growth 5Y40.63%
EBIT Next Year19.41%
EBIT Next 3Y11.06%
EBIT Next 5Y12.68%
FCF growth 1Y-2.2%
FCF growth 3Y16.8%
FCF growth 5Y6.94%
OCF growth 1Y-2.94%
OCF growth 3Y16.37%
OCF growth 5Y8.2%

INGERSOLL-RAND INC / IR Fundamental Analysis FAQ

What is the fundamental rating for IR stock?

ChartMill assigns a fundamental rating of 5 / 10 to IR.


Can you provide the valuation status for INGERSOLL-RAND INC?

ChartMill assigns a valuation rating of 2 / 10 to INGERSOLL-RAND INC (IR). This can be considered as Overvalued.


How profitable is INGERSOLL-RAND INC (IR) stock?

INGERSOLL-RAND INC (IR) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for IR stock?

The Price/Earnings (PE) ratio for INGERSOLL-RAND INC (IR) is 24.37 and the Price/Book (PB) ratio is 3.16.


What is the earnings growth outlook for INGERSOLL-RAND INC?

The Earnings per Share (EPS) of INGERSOLL-RAND INC (IR) is expected to grow by 9.21% in the next year.